ScholarIQanswers from OpenAlex
PharmAccess Group
InstitutionResearch output, impact & collaborations
PharmAccess Group is a institution indexed in ScholarIQ from OpenAlex.
What is known about PharmAccess Group?
ScholarIQrecord summary
PharmAccess Group is a research organisation in Amsterdam, NL. OpenAlex records 1,085 works and 17,868 citations for it. 767 researchers list it as their most recent affiliation.
How many works does PharmAccess Group have?
ScholarIQindexed works
PharmAccess Group has 1,085 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does PharmAccess Group have?
ScholarIQcitation count
PharmAccess Group has 17,868 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at PharmAccess Group?
ScholarIQresearcher count
PharmAccess Group has 767 researchers in the ScholarIQ index.
What is the average h-index at PharmAccess Group?
ScholarIQavg h-index
PharmAccess Group has an average h-index of 24.3 in OpenAlex.
What is the ROR of PharmAccess Group?
ScholarIQror
The ROR for PharmAccess Group is on the source record.
What is the OpenAlex record for PharmAccess Group?
ScholarIQopenalex
The OpenAlex for PharmAccess Group is on the source record.
Who are the most-cited researchers behind PharmAccess Group?
ScholarIQtop researchers by citations
What are the most-cited papers on PharmAccess Group?
ScholarIQmost cited works
Impact of the societal response to COVID-19 on access to healthcare for non-COVID-19 health issues in slum communities of Bangladesh, Kenya, Nigeria and Pakistan: results of pre-COVID and COVID-19 lockdown stakeholder engagements
Syed Ahsanuddin Ahmed, Motunrayo Ajisola, Kehkashan Azeem, Pauline Bakibinga, Yen‐Fu Chen, Nazratun Nayeem Choudhury, Olufunke Fayehun, Frances Griffiths, Bronwyn Harris, Peter Kibe, Richard Lilford, Akinyinka Omigbodun, Narjis Rizvi, Jo Sartori, Simon Smith, Sam Watson, Ria Wilson, Godwin Yeboah, Navneet Aujla, Iqbal Azam, Peter J. Diggle, Paramjit Gill, Romaina Iqbal, Caroline Kabaria, Lyagamula Kisia, Catherine Kyobutungi, Jason Madan, Blessing Mberu, Shukri F. Mohamed, Ahsana Nazish, Oladoyin Odubanjo, Mary E. Osuh, Eme Owoaje, Oyinlola Oyebode, João Porto de Albuquerque, Omar Rahman, Komal Tabani, Olalekan John Taiwo, Grant Tregonning, Olalekan A. Uthman, Rita Yusuf
H3Africa AWI-Gen Collaborative Centre: a resource to study the interplay between genomic and environmental risk factors for cardiometabolic diseases in four sub-Saharan African countries
Michèle Ramsay, Nigel J. Crowther, Ernest Tambo, Godfred Agongo, Vukosi Baloyi, S.A. Dikotope, F. Xavier Gómez‐Olivé, Nicole G. Jaff, Hermann Sorgho, Ryan G. Wagner, Christopher Khayeka‐Wandabwa, Ananyo Choudhury, Scott Hazelhurst, Kathleen Kahn, Zané Lombard, Freedom Mukomana, Cassandra Claire Soo, Himla Soodyall, Alisha N. Wade, Sulaimon Afolabi, Isaiah Agorinya, Lucas Amenga–Etego, Stuart A. Ali, Joel D. Bognini, Palwendé Romuald Boua, Cornelius Debpuur, S. Diallo, E. Fato, Adama Kazienga, Sophie Z. Konkobo, Patrice Kouraogo, Felistas Mashinya, Lisa K. Micklesfield, Seydou Nakanabo‐Diallo, Brian Njamwea, Engelbert A. Nonterah, Samiratou Ouédraogo, Venesa Pillay, A. M. Somande, Paulina Tindana, Rhian Twine, Marianne Alberts, Catherine Kyobutungi, Shane A. Norris, Abraham Oduro, Halidou Tinto, Stephen Tollman, Osman Sankoh
Data Interoperability in Context: The Importance of Open-Source Implementations When Choosing Open Standards
D. Kapitan, Femke Heddema, André Dekker, Melle Sieswerda, Bart-Jan Verhoeff, Matt Berg
Curation of federated patient data: a proposed landscape for the African Health Data Space
Mirjam van Reisen, Samson Yohannes Amare, Ruduan Plug, Getu Tadele, Tesfit Gebremeskel, Abdullahi Abubakar Kawu, Kai Smits, Liya Mamo Woldu, Joëlle Stocker, Femke Heddema, Sakinat Oluwabukonla Folorunso, Rens Kievit, Araya Abrha Medhanyie
Data Interoperability in Context: The Importance of Open-Source Implementations When Choosing Open Standards (Preprint)
D. Kapitan, Femke Heddema, André Dekker, Melle Sieswerda, Bart-Jan Verhoeff, Matt Berg
How much of the research on PharmAccess Group is open access?
ScholarIQopen access share
83%OPEN ACCESS